AEGLEA BIOTHERAPEUTICS

Aeglea BioTherapeutics designs and develops human enzyme therapeutics for rare genetic diseases and cancer. Pegzilarginase, a recombinant human arginase 1 enzyme, is the company's product candidate now in clinical testing.

AEGLEA BIOTHERAPEUTICS

Social Links:

Facebook

Twitter

Industry:

Biotechnology Health Care Therapeutics

Founded:

2013-01-01

Address:

Austin, Texas, United States

Country:

United States

Website Url:

http://www.aeglea.com

Total Employee:

101+

Status:

Active

Contact:

+1 512 942 2935

Email Addresses:

[email protected]

Total Funding:

56 M USD

Technology used in webpage:

SPF Microsoft Exchange Online Amazon Office 365 Mail IPv6 GoDaddy DNS Microsoft Gravity Forms AWS Global Accelerator WP Engine

Similar Organizations

alethia-biotherapeutics-logo

Alethia BioTherapeutics

Alethia BioTherapeutics is a biotechnology company developing monoclonal antibody-based therapeutics for cancer-associated diseases.

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

araim-pharmaceuticals-logo

Araim Pharmaceuticals

Araim Pharmaceuticals is a clinical-stage biotechnology company that offers technology to address injuries and chronic diseases.

calidi-biotherapeutics-logo

Calidi Biotherapeutics

Calidi Biotherapeutics is a clinical-stage biotechnology company at the forefront of oncolytic virus-based immunotherapies for cancer.

cedilla-therapeutics-logo

Cedilla Therapeutics

Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.

electra-therapeutics-logo

Electra Therapeutics

Electra Therapeutics is a clinical stage biotechnology company developing therapies for cancer and other immunological diseases.

juventas-therapeutics-logo

Juventas Therapeutics

Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

Current Advisors List

alison-lawton_image

Alison Lawton Board Member @ Aeglea BioTherapeutics
Board_member

Current Employees Featured

leslie-sloan_image

Leslie Sloan
Leslie Sloan Chief Operating Officer @ Aeglea BioTherapeutics
Chief Operating Officer

scott-w-rowlinson_image

Scott W Rowlinson
Scott W Rowlinson VP Research & Development @ Aeglea BioTherapeutics
VP Research & Development
2014-02-01

anthony-quinn_image

Anthony Quinn
Anthony Quinn President & Chief Executive Officer @ Aeglea BioTherapeutics
President & Chief Executive Officer
2018-07-01

michael-c-hanley_image

Michael C. Hanley
Michael C. Hanley Chief Commercial Officer @ Aeglea BioTherapeutics
Chief Commercial Officer

eric-bradford_image

Eric Bradford
Eric Bradford Chief Development Officer @ Aeglea BioTherapeutics
Chief Development Officer

james-wooldridge_image

James Wooldridge
James Wooldridge Chief Medical Officer @ Aeglea BioTherapeutics
Chief Medical Officer

not_available_image

Ann M. Lowe
Ann M. Lowe Consulting Chief Medical Officer @ Aeglea BioTherapeutics
Consulting Chief Medical Officer

aaron-schuchart_image

Aaron Schuchart
Aaron Schuchart Chief Business Officer @ Aeglea BioTherapeutics
Chief Business Officer
2020-05-01

joseph-e-tyler_image

Joseph E Tyler
Joseph E Tyler Vice President of Manufacturing @ Aeglea BioTherapeutics
Vice President of Manufacturing
2013-12-01

Founder

david-lowe_image

David Lowe

Stock Details

Company's stock symbol is NASDAQ:AGLE

Investors List

ut-horizon-fund_image

Official Site Inspections

http://www.aeglea.com Semrush global rank: 2.35 M Semrush visits lastest month: 7.91 K

Host Informations
Whois Informations

Loading ...